Cala Health
Cala Health: Pioneering bioelectronic medicine for transformative chronic disease care.
Founded
2014Cala Health: Pioneering bioelectronic medicine for transformative chronic disease care.
Cala Health holds a noninvasive prescription niche in tremor care, offering a wrist-worn alternative to drugs and deep brain stimulation, per MobiHealthNews. Its TAPS platform is backed by multiple FDA clearances and Medicare coverage for qualifying beneficiaries, which lowers adoption friction.
The MyCala portal and personalized stimulation create a data feedback loop between patients and clinicians that oral drugs do not offer at home. Fresh growth capital of 50 million dollars from Trinity Capital in April 2026 funds commercial expansion and product innovation, per the same report.
Source: mobihealthnews.com
Cala Health is scaling prescription wearable neuromodulation as payer coverage widens, with Medicare and VA pathways established and commercial plans targeted next, per MobiHealthNews. The April 2026 kIQ Plus clearance adds therapy modes that support differentiation in essential tremor and Parkinson care.
Growth funding of 50 million dollars from Trinity Capital positions the company to expand commercial reach and invest in product innovation, per the same report. Continued clinical presentations, such as the 2026 American Academy of Neurology data, should support clinician adoption if responder rates hold.
Source: parkinsonsnewstoday.com
Cala Health sells the Cala kIQ System, a prescription wrist-worn device delivering Transcutaneous Afferent Patterned Stimulation for action hand tremor in essential tremor and Parkinson disease, as described on its official site. The device personalizes stimulation from measured tremor patterns and pairs with the MyCala patient portal for therapy data and clinician reports.
In April 2026 the company announced FDA clearance of the next-generation Cala kIQ Plus system with added therapy modes and adaptive calibration, per its PR Newswire release. Medicare covers Cala TAPS therapy for qualifying beneficiaries, and the system is available through the VA at no cost to eligible veterans, per Parkinson News Today.
Source: